Integra lifesciences holdings corp (IART)
CashFlow / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11Dec'10Sep'10Jun'10Mar'10
OPERATING ACTIVITIES:
Net Income (Loss) Attributable to Parent

26,625

50,201

60,020

100,925

82,565

60,801

80,018

69,881

69,341

64,743

48,636

65,621

67,539

74,564

61,296

9,272

1,516

-3,519

-1,333

40,355

40,182

34,004

30,609

-9,528

-12,833

-21,067

-22,052

21,489

28,483

41,204

32,978

31,010

23,195

27,989

42,236

47,476

61,934

65,669

0

0

0

Adjustments to reconcile net income to net cash provided by operating activities:
Loss from discontinued operations, net of tax

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-10,370

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Depreciation and amortization

111,520

109,462

109,261

110,713

110,727

110,730

109,717

101,635

96,324

88,945

80,593

77,710

74,129

72,665

72,620

70,768

65,316

58,863

52,988

41,632

44,273

46,434

29,360

36,152

33,585

31,013

49,184

50,828

51,424

52,611

51,991

51,529

52,790

50,172

47,807

44,669

39,699

39,172

0

0

0

Non-cash impairment charges

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

790

-45,798

940

940

340

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Deferred income tax benefit/provision

-7,135

-19,046

-19,509

-16,838

-13,391

-8,184

-65,580

-66,589

-68,947

-67,304

-4,490

-6,970

-6,347

-6,474

-35,848

-2,558

-1,812

-351

25,818

-4,781

-7,071

-6,849

5,808

-1,444

1,277

-1,341

-2,517

3,691

1,465

1,537

2,422

3,811

2,154

1,156

1,342

-706

2,516

4,128

0

0

0

Share-based compensation

20,922

21,255

20,737

20,424

20,131

20,779

20,977

20,714

20,918

21,550

20,896

20,463

19,408

17,310

16,435

17,928

16,427

15,450

15,108

11,671

14,371

14,554

13,482

13,380

10,241

9,842

10,013

9,460

9,053

9,051

14,540

15,297

24,841

26,805

24,653

25,552

17,400

17,209

0

0

0

Amortization of debt issuance costs and expenses associated with debt refinancing

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Amortization of debt issuance costs

-

-

-

-

-

6,270

6,497

5,595

3,848

2,722

2,084

2,077

2,306

2,529

2,242

2,440

2,350

2,264

2,156

2,388

2,493

2,571

2,651

2,447

2,361

2,298

2,329

2,339

2,510

2,725

2,860

3,029

3,630

3,387

3,055

2,654

1,650

1,490

0

0

0

Non-cash lease expense

0

-

-

-

0

-

-

-

-

-

-

-

-

8,074

8,337

8,335

8,116

7,911

7,722

7,415

7,297

7,104

6,854

6,664

6,519

6,463

5,101

5,256

6,602

8,520

11,756

13,455

12,485

10,591

8,725

6,816

6,706

7,125

0

0

0

Loss on disposal of property and equipment

-1,828

-1,821

-1,260

-1,869

-1,606

-1,385

-7,515

-6,664

-6,787

-6,989

-1,162

-1,033

-2,052

-1,765

-1,403

-1,627

-561

-481

-528

-569

-890

-909

-654

-512

-100

-1,965

-2,321

-2,712

-3,177

-1,312

0

0

0

-

-

-

-

0

0

0

0

Change in fair value of contingent consideration and others

-126

1,119

10

310

1,029

1,214

-723

-1,801

-4,592

-4,710

-2,867

-2,259

117

-13

-101

189

183

177

2,001

2,001

761

764

0

0

0

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

Changes in assets and liabilities:
Excess tax benefits from stock-based compensation arrangements

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

1,337

1,332

788

270

3,342

3,318

3,654

3,634

436

488

798

848

949

884

721

3,580

0

0

0

Changes in assets and liabilities, net of business acquisitions:
Accounts receivable

-32,578

9,428

35,720

38,957

12,326

17,021

78,657

86,815

107,509

89,698

19,279

15,296

-333

17,518

15,125

24,564

35,225

16,231

13,942

22,443

22,262

17,145

12,839

-1,861

-4,572

-1,010

-6,556

-786

-1,092

-3,783

2,434

-1,075

-1,826

1,878

303

7,171

5,965

3,783

0

0

0

Inventories

57,496

43,308

18,812

9,662

5,045

-8,300

2,480

-1,967

-6,603

-99

1,377

7,678

6,679

9,576

4,815

5,003

6,999

3,759

8,352

12,889

20,486

24,138

22,390

25,333

29,141

27,364

30,556

17,954

6,597

711

-9,570

-9,097

-5,619

-1,702

5,759

9,170

9,945

7,374

0

0

0

Prepaid expenses and other current assets

-30,703

-13,071

7,661

8,914

21,179

-3,933

15,685

26,531

19,657

33,808

830

-1,314

-11,636

-14,912

6,605

-3,226

3,774

233

-12,383

-20,261

-22,937

-16,526

-14,256

-458

2,290

-1,996

11,909

12,025

1,982

3,067

-8,299

-6,077

1,647

395

11,102

1,383

2,760

6,452

0

0

0

Other non-current assets

-16,784

-13,156

-9,099

-4,334

-85

-1,052

334

-461

254

914

1,900

1,715

195

475

1,166

-1,845

-577

-610

7,487

10,874

11,355

10,914

-184

-394

-1,860

-1,872

191

45

516

553

441

376

-138

-375

31

506

290

179

0

0

0

Accounts payable, accrued expenses and other current liabilities

-30,956

14,666

-5,464

23,403

6,001

3,588

80,718

71,629

88,106

95,321

17,776

17,636

-2,282

-414

-1,754

-13,506

24,612

8,208

12,076

19,914

902

811

-8,323

3,289

-2,589

1,334

-13,414

-25,556

-23,707

-21,071

-1,129

-8,888

-6,924

-11,842

-9,798

5,119

743

6,736

0

0

0

Contract liabilities

-81

-607

220

-376

1,316

1,504

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,702

3,451

2,432

136

-136

125

328

1,118

780

607

327

697

848

-484

-126

-1,051

7

923

198

104

-706

-850

-629

-457

0

0

0

Other non-current liabilities

-8,951

-2,059

442

-3,315

5,068

391

21,907

35,380

29,419

23,803

3,280

-5,118

-4,708

591

770

-831

-962

945

800

-705

-399

-4,357

-2,806

-1,255

-914

1,159

-940

-1,909

-1,702

-939

-3,139

-2,445

-2,557

-3,154

0

0

0

-

-

-

-

Net cash provided by operating activities of continuing operations

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

117,063

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash used in operating activities of discontinued operations

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-12,209

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other liabilities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

Net cash provided by operating activities

222,763

231,433

184,937

199,947

187,636

199,683

168,544

134,535

127,193

114,544

109,524

111,049

120,257

116,405

135,516

108,360

98,265

104,854

104,073

115,537

103,930

83,565

70,402

70,135

56,676

53,268

38,169

35,270

34,628

59,100

97,198

93,084

115,391

104,328

98,063

103,914

98,689

105,571

0

0

0

INVESTING ACTIVITIES:
Purchases of property and equipment

69,970

69,537

73,028

76,104

78,440

77,741

65,753

56,880

49,699

43,503

50,998

50,176

45,624

47,328

39,235

37,622

38,978

33,413

31,546

32,602

32,335

38,340

31,687

38,517

42,783

42,301

62,394

68,864

69,472

69,031

57,403

49,929

42,915

38,425

43,622

38,585

49,004

37,138

0

0

0

Cash used in business acquisitions, net of cash acquired

-

-

-

-

-

-

-

-

-

-

-

-

-

-225

0

0

0

-

-

-

-

320,921

235,000

235,150

235,214

2,980

8,081

7,241

9,869

7,278

0

0

0

-

-

-

-

-

-

-

-

Acquired in-process research and development

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Change in restricted cash

-

-

-

-

-

-

-

-

-

-

-

-

-

-4,165

8,252

8,252

8,252

4,087

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from sale of short-term investments

-

-

-

-

-

-

-

-

-

-16,951

-16,951

-16,951

-9,976

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from note receivable

507

752

983

959

934

910

679

929

704

483

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from sale of property and equipment

36

37

160

252

309

422

434

355

441

293

0

0

0

-

-

-

-

1,438

1,438

1,438

1,438

0

2

5

3

535

533

530

532

0

0

0

0

-

-

-

-

-

-

-

-

Cash provided by (used in) business acquisition

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Cash provided by business acquisitions

-

-

-

-

-

-

-

0

0

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Purchases of short-term investments

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

67,907

0

0

0

-

-

-

-

-

-

-

-

Net cash used in investing activities of continuing operations

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-364,950

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash used in investing activities of discontinued operations

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-7,060

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from working capital purchase price adjustment

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash used in investing activities

-168,347

-162,668

-167,389

-74,893

-56,213

-49,705

-1,007,943

-998,707

-1,037,490

-1,221,335

-258,909

-258,509

-229,035

-42,622

-59,298

-368,039

-373,108

-372,010

-433,043

-126,370

-122,614

-363,317

-274,593

-279,212

-283,544

-50,296

-69,942

-36,693

-28,528

-79,276

-65,078

-165,797

-248,289

-190,376

0

0

0

-

-

-

-

FINANCING ACTIVITIES:
Proceeds from borrowings of long-term indebtedness

282,900

236,900

337,000

222,400

213,400

171,200

785,617

1,112,000

1,122,000

1,307,000

1,236,383

910,000

875,000

680,000

15,000

525,000

560,000

545,000

585,000

225,000

190,000

425,000

385,000

245,000

265,000

30,000

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Payments on debt

532,900

246,100

343,250

350,000

682,400

660,000

512,000

502,000

132,000

117,000

527,500

512,500

529,375

511,250

65,625

479,375

452,500

465,625

483,750

210,000

210,000

195,000

0

0

0

-

-

-

-

12,812

35,624

37,499

184,375

213,437

192,500

190,625

43,750

16,875

0

0

0

Purchase of option hedge on convertible notes

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Payment of capital lease obligation

-

-

-

-

-

-

-

-

-

-

-

-

-

653

643

636

691

709

788

756

661

605

370

245

122

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from Convertible Debt

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from sale of stock purchase warrants

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Payment of debt issuance costs

20,264

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash paid for contingent consideration

-

-

-

-

-

-

0

0

0

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Purchases of treasury stock

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

83,463

0

0

0

-

-

-

-

Proceeds from exercised stock options

7,501

6,948

7,101

7,878

7,480

9,392

9,239

3,727

12,269

9,774

10,330

10,995

10,610

10,481

9,925

9,260

8,152

7,345

14,243

14,243

7,691

15,215

10,241

10,427

9,865

2,344

420

680

680

696

849

650

2,260

3,697

13,988

14,810

15,209

16,146

0

0

0

Cash taxes paid in net equity settlement

4,705

6,514

6,678

6,793

20,754

7,821

21,301

20,861

6,475

7,123

-7,047

-7,080

-6,928

-4,851

-4,701

-4,490

-11,752

-6,580

-10,371

-10,241

-2,138

-2,718

1,337

1,332

788

270

3,342

3,318

3,654

3,634

436

488

798

848

949

884

721

3,580

0

0

0

Net cash provided by financing activities

147,846

-8,766

-10,829

-131,693

-154,593

-180,872

567,397

893,606

963,022

1,168,947

518,496

212,329

159,971

-15,116

-46,639

218,470

271,920

248,142

273,540

15,036

-18,318

238,682

230,556

243,932

261,936

19,019

22,324

22,600

24,567

11,750

-18,174

17,743

92,032

60,137

125,918

52,537

-36,565

-1,574

0

0

0

Effect of exchange rate changes on cash and cash equivalents

-1,575

74

-4,729

-1,048

-9,201

-5,203

-3,950

-263

12,558

10,724

5,234

2,928

-4,166

-4,744

-1,552

-3,285

138

-4,848

-5,230

-10,066

-12,165

-7,550

-5,002

3,669

4,279

1,685

2,599

1,989

382

4,556

781

-6,839

-4,846

-2,044

-1,773

9,351

2,850

-4,809

0

0

0

Net increase in cash and cash equivalents

200,687

60,073

1,990

-7,687

-32,371

-36,097

-275,952

29,171

65,283

72,880

374,345

67,797

47,027

53,923

28,027

-44,494

-2,785

-23,862

-60,660

-5,863

-49,167

-48,620

21,363

38,524

39,347

23,676

-6,850

23,166

31,049

-3,870

14,727

-61,809

-45,712

-27,955

28,159

43,661

22,680

56,872

0

0

0